Just 25 years ago, venous thromboembolism treatment regimens were primitive, writes Dr Holley. But two trials showed that apixaban and rivaroxaban are proving excellent options for tackling VTE.

This year, the sports pages have brought a serious health concern back into the spotlight. NBA stars Victor Wembanyama and ...